Oropharyngeal colostrum immunotherapy and nutrition in preterm newborns: meta-analysis

Michelle de Santana Xavier Ramos1,2, Camilla da Cruz Martins1, Elivan Silva Souza3

  • 1Universidade Estadual de Feira de Santana. Departamento de Saúde. Feira de Santana, BA, Brasil.

Revista De Saude Publica
|December 21, 2021
PubMed

Insights

Oropharyngeal colostrum immunotherapy significantly reduced the time for very low birth weight preterm newborns to achieve full enteral nutrition. This intervention offers a promising approach for improving feeding outcomes in vulnerable infants.

Area of Science:

  • Neonatalogy
  • Immunology
  • Gastroenterology

Background:

  • Very low birth weight preterm newborns (VLBW-PTNB) often face challenges in achieving full enteral nutrition.
  • Early initiation of nutrition is crucial for growth and development in preterm infants.
  • Oropharyngeal colostrum administration is being explored as a method to enhance feeding tolerance.

Purpose of the Study:

  • To investigate the efficacy of oropharyngeal colostrum immunotherapy in shortening the time to full enteral nutrition for VLBW-PTNB.
  • To compare feeding outcomes between VLBW-PTNB receiving oropharyngeal colostrum immunotherapy and those receiving placebo or routine care.

Main Methods:

  • A systematic literature search was conducted across multiple databases and gray literature.
  • Randomized clinical trials were included without date or language restrictions.
  • A random-effects meta-analysis was performed on data from 764 VLBW-PTNB across five selected studies.

Main Results:

  • Meta-analysis of five studies involving 708 VLBW-PTNB indicated a mean difference of -4.26 days to achieve full enteral nutrition.
  • Three studies reported shorter feeding times in the immunotherapy group.
  • High heterogeneity (I2 = 83.1%) was observed among the studies.

Conclusions:

  • Oropharyngeal colostrum immunotherapy demonstrates potential in reducing the time for VLBW-PTNB to reach full enteral nutrition.
  • This therapeutic approach may offer benefits over placebo or standard care in improving feeding progression for preterm infants.
  • Further research may be warranted to explore optimal protocols and long-term outcomes.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
451
Enteral Nutrition I: Orogastric and Nasogastric Feeding01:26

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...
537
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
341
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
497
Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

Parentral Nutrition: Centeral and Peripheral Parental Nutrition

Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
346
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
28